516 related articles for article (PubMed ID: 7828614)
1. HMPAO SPET and FDG PET in Alzheimer's disease and vascular dementia: comparison of perfusion and metabolic pattern.
Mielke R; Pietrzyk U; Jacobs A; Fink GR; Ichimiya A; Kessler J; Herholz K; Heiss WD
Eur J Nucl Med; 1994 Oct; 21(10):1052-60. PubMed ID: 7828614
[TBL] [Abstract][Full Text] [Related]
2. Regional cerebral blood flow single-photon emission tomography with 99mTc-HMPAO and the acetazolamide test in the evaluation of vascular and Alzheimer's dementia.
Pávics L; Grünwald F; Reichmann K; Horn R; Kitschenberg A; Hartmann A; Menzel C; Schomburg AG; Overbeck B; Csernay L; Biersack HJ
Eur J Nucl Med; 1999 Mar; 26(3):239-45. PubMed ID: 10079314
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic value of FDG-PET and HMPAO-SPET in patients with mild dementia and mild cognitive impairment: metabolic index and perfusion index.
Döbert N; Pantel J; Frölich L; Hamscho N; Menzel C; Grünwald F
Dement Geriatr Cogn Disord; 2005; 20(2-3):63-70. PubMed ID: 15908747
[TBL] [Abstract][Full Text] [Related]
4. Assessment of cerebral perfusion with single-photon emission tomography in normal subjects and in patients with Alzheimer's disease: effects of region of interest selection.
Claus JJ; van Harskamp F; Breteler MM; Krenning EP; van der Cammen TJ; Hofman A; Hasan D
Eur J Nucl Med; 1994 Oct; 21(10):1044-51. PubMed ID: 7828613
[TBL] [Abstract][Full Text] [Related]
5. Brain perfusion scintigraphy with 99mTc-HMPAO or 99mTc-ECD and 123I-beta-CIT single-photon emission tomography in dementia of the Alzheimer-type and diffuse Lewy body disease.
Donnemiller E; Heilmann J; Wenning GK; Berger W; Decristoforo C; Moncayo R; Poewe W; Ransmayr G
Eur J Nucl Med; 1997 Mar; 24(3):320-5. PubMed ID: 9143472
[TBL] [Abstract][Full Text] [Related]
6. [Molecular neuroimaging in the study of cognitive impairment: contribution of the cerebral blood flow SPECT with 99mTc-HMPAO and 18F-FDG PET/CT scan].
Banzo I; Quirce R; Martínez-Rodríguez I; Jiménez-Bonilla J; Portilla-Quattrociocchi H; Medina-Quiroz P; Ortega F; Rodríguez E; Mateo I; Vázquez-Higuera JL; de Arcocha M; Carril JM
Rev Esp Med Nucl; 2011; 30(5):301-6. PubMed ID: 21640440
[TBL] [Abstract][Full Text] [Related]
7. 18FDG PET and acetazolamide-enhanced 99mTc-HMPAO SPET in systemic lupus erythematosus.
Grünwald F; Schomburg A; Badali A; Ruhlmann J; Pavics L; Biersack HJ
Eur J Nucl Med; 1995 Sep; 22(9):1073-7. PubMed ID: 7588946
[TBL] [Abstract][Full Text] [Related]
8. Positron emission tomography for diagnosis of Alzheimer's disease and vascular dementia.
Mielke R; Heiss WD
J Neural Transm Suppl; 1998; 53():237-50. PubMed ID: 9700661
[TBL] [Abstract][Full Text] [Related]
9. A comparison of (99m)Tc-HMPAO SPET changes in dementia with Lewy bodies and Alzheimer's disease using statistical parametric mapping.
Colloby SJ; Fenwick JD; Williams ED; Paling SM; Lobotesis K; Ballard C; McKeith I; O'Brien JT
Eur J Nucl Med Mol Imaging; 2002 May; 29(5):615-22. PubMed ID: 11976799
[TBL] [Abstract][Full Text] [Related]
10. Voxel-based comparison of rCBF SPET images in frontotemporal dementia and Alzheimer's disease highlights the involvement of different cortical networks.
Varrone A; Pappatà S; Caracò C; Soricelli A; Milan G; Quarantelli M; Alfano B; Postiglione A; Salvatore M
Eur J Nucl Med Mol Imaging; 2002 Nov; 29(11):1447-54. PubMed ID: 12397463
[TBL] [Abstract][Full Text] [Related]
11. High-resolution technetium-99m-HMPAO SPECT in patients with probable Alzheimer's disease: comparison with fluorine-18-FDG PET.
Messa C; Perani D; Lucignani G; Zenorini A; Zito F; Rizzo G; Grassi F; Del Sole A; Franceschi M; Gilardi MC
J Nucl Med; 1994 Feb; 35(2):210-6. PubMed ID: 8294987
[TBL] [Abstract][Full Text] [Related]
12. Functional neuroimaging in Alzheimer's disease: how far should we go?
Kerwin R
Eur J Nucl Med; 1994 Oct; 21(10):1041-3. PubMed ID: 7828612
[No Abstract] [Full Text] [Related]
13. Comparison of technetium-99m-HMPAO and technetium-99m-ECD cerebral SPECT images in Alzheimer's disease.
van Dyck CH; Lin CH; Smith EO; Wisniewski G; Cellar J; Robinson R; Narayan M; Bennett A; Delaney RC; Bronen RA; Hoffer PB
J Nucl Med; 1996 Nov; 37(11):1749-55. PubMed ID: 8917168
[TBL] [Abstract][Full Text] [Related]
14. 99mTc-HMPAO and 99mTc-ECD perform differently in typically hypoperfused areas in Alzheimer's disease.
Koulibaly PM; Nobili F; Migneco O; Vitali P; Robert PH; Girtler N; Darcourt J; Rodriguez G
Eur J Nucl Med Mol Imaging; 2003 Jul; 30(7):1009-13. PubMed ID: 12750851
[TBL] [Abstract][Full Text] [Related]
15. A multi-institutional study of interobserver agreement in the evaluation of dementia with rCBF/SPET technetium-99m exametazime (HMPAO).
Hellman RS; Tikofsky RS; Van Heertum R; Coade G; Carretta R; Hoffmann RG
Eur J Nucl Med; 1994 Apr; 21(4):306-13. PubMed ID: 8005154
[TBL] [Abstract][Full Text] [Related]
16. Regional differences between 99mTc-ECD and 99mTc-HMPAO SPET in perfusion changes with age and gender in healthy adults.
Inoue K; Nakagawa M; Goto R; Kinomura S; Sato T; Sato K; Fukuda H
Eur J Nucl Med Mol Imaging; 2003 Nov; 30(11):1489-97. PubMed ID: 14579088
[TBL] [Abstract][Full Text] [Related]
17. Memory functions and rCBF (99m)Tc-HMPAO SPET: developing diagnostics in Alzheimer's disease.
Elgh E; Sundström T; Näsman B; Ahlström R; Nyberg L
Eur J Nucl Med Mol Imaging; 2002 Sep; 29(9):1140-8. PubMed ID: 12192558
[TBL] [Abstract][Full Text] [Related]
18. FDG PET and differential diagnosis of dementia.
Herholz K
Alzheimer Dis Assoc Disord; 1995; 9(1):6-16. PubMed ID: 7605624
[TBL] [Abstract][Full Text] [Related]
19. Vascular dementia of Binswanger's type: clinical, neuroradiological and 99mTc-HMPAO SPET study.
Shyu WC; Lin JC; Shen CC; Hsu YD; Lee CC; Shiah IS; Tsao WL
Eur J Nucl Med; 1996 Oct; 23(10):1338-44. PubMed ID: 8781138
[TBL] [Abstract][Full Text] [Related]
20. Quantitative topographical EEG compared to FDG PET for classification of vascular and degenerative dementia.
Szelies B; Mielke R; Herholz K; Heiss WD
Electroencephalogr Clin Neurophysiol; 1994 Aug; 91(2):131-9. PubMed ID: 7519142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
